ReDati DaRebai, Li Weikun, Jiang Yujuan, Yang Xinhui, Lei Cheng, Wang Haijiang, Liang Jianwei
Department of Gastrointestinal Surgery, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Front Oncol. 2024 Jan 29;13:1252253. doi: 10.3389/fonc.2023.1252253. eCollection 2023.
Natural orifice specimen extraction surgery (NOSES) has been widely applied to the treatment of colorectal cancer. This study aim to investigate the short-term and survival outcomes of transrectal specimen extraction after laparoscopic right hemicolectomy.
From January 2016 to December 2021, a total of 166 consecutive patients with right colon cancer who underwent laparoscopic right hemicolectomy in Cancer Hospital of Chinese Academy of Medical Sciences and Beijing Hospital were identified. Baseline data, perioperative parameters, anal function, inflammatory indicators and survival outcomes were collected and compared.
Totally, 24 patients who underwent transrectal NOSE were matched with 24 patients who received conventional laparoscopic surgery (LAP). Patients in NOSES group had a significantly lower incidence of incision infection (0 vs 20.8%, =0.048), faster recovery of gastrointestinal function (2.1 vs 3,1 days, =0.032) compared with those in LAP group. In addition, patients in the NOSE group experienced significantly less postoperative pain on POD1 (2.3 vs 4.4, <0.001), POD3 (2.1 vs 3.9, <0.001), and POD5 (1.7 vs 2.8, =0.011). Regarding to anal function 6 months after surgery, no significant difference was observed in Wexner incontinence scale (9.8 vs 9.5, =0.559) between the two groups. In terms of indicators of the inflammatory response, there were no significant differences in body temperature, neutrophils, and PCT levels between the two groups. However, CRP levels in the NOSES group on POD 3 (6.9 vs 5.1 mg/L, =0.016) and POD 5 (3.8 vs 2.6 mg/L, =0.027) were significantly higher than in the LAP group. With regarded to survival outcomes, patients in the NOSES group were similar to those in the LAP group for 3-year OS (100% vs 91.2%, =0.949), 3-year DFS (86.2% vs 84.8%, =0.949), and 3-year LRFS (94.2% vs 88.7%, =0.549).
For total laparoscopic right hemicolectomy, transrectal NOSE is effective and safe, and associated with lower incidence of wound infection, less pain, faster recovery, and similar survival outcomes compared to conventional laparoscopic surgery.
经自然腔道标本取出手术(NOSES)已广泛应用于结直肠癌的治疗。本研究旨在探讨腹腔镜右半结肠切除术后经直肠标本取出的短期和生存结局。
2016年1月至2021年12月,在中国医学科学院肿瘤医院和北京医院共纳入166例连续接受腹腔镜右半结肠切除术的右结肠癌患者。收集并比较基线数据、围手术期参数、肛门功能、炎症指标和生存结局。
共有24例行经直肠NOSES的患者与24例接受传统腹腔镜手术(LAP)的患者进行匹配。与LAP组相比,NOSES组患者的切口感染发生率显著更低(0%对20.8%,P=0.048),胃肠功能恢复更快(2.1天对3.1天,P=0.032)。此外,NOSES组患者在术后第1天(2.3对4.4,P<0.001)、第3天(2.1对3.9,P<0.001)和第5天(1.7对2.8,P=0.011)的术后疼痛明显更少。关于术后6个月的肛门功能,两组间韦克斯纳失禁量表评分无显著差异(9.8对9.5,P=0.559)。在炎症反应指标方面,两组间体温、中性粒细胞和降钙素原水平无显著差异。然而,NOSES组在术后第3天(6.9对5.1mg/L,P=0.016)和第5天(3.8对2.6mg/L,P=0.027)的CRP水平显著高于LAP组。关于生存结局,NOSES组患者与LAP组患者在3年总生存率(100%对91.2%,P=0.949)、3年无病生存率(86.2%对84.8%,P=0.949)和3年局部复发无病生存率(94.2%对88.7%,P=0.549)方面相似。
对于全腹腔镜右半结肠切除术,经直肠NOSES是有效且安全的,与传统腹腔镜手术相比,其伤口感染发生率更低、疼痛更少、恢复更快且生存结局相似。